 Hello. Good evening, Slush. What a wonderful two days. My name is Nikunj Malpani. I am the co-founder and CEO of NeoDocs. We are building low-cost diagnostics on the phone. Now, I'll tell you shortly what does that mean. NeoDocs was started by three of us, myself, Pratik and Anurag. All three of us are engineers from IIT, Bombay in India. We all know health tracking is becoming a cultural phenomenon. We are exercising on a daily basis. We are taking supplements, healthy alternatives. We are getting tested more and more often. And this is not just a story in Europe and US, but all over the world. At the same time, diagnostics has evolved in a very, very interesting manner. Around 50 years ago, diagnostic labs were set up. 15-20 years ago, we had Flebo-Thomas, who used to come home, collect samples, take it back to the lab and we used to get the results. Around five to ten years ago, we started having fitness wearable smartwatches, where you can track non-invasive biomarkers using your watch. And today, the time is right to build your personal lab on the phone at one-tenth the cost with continuous tracking. At NeoDocs, we are building instant testing kits that you can do on the phone. You take the test, click a photo and results are ready in 30 seconds. On the simple device, I won't even call it a device, on the simple piece of paper. I don't think all of you can look at it very clearly, so my co-founder Pratik will be distributing a few samples in the audience. We are creating a variety of tests. We started with urine-based tests. We are solving for urinary tract infection, chronic kidney disease, liver health, hydration and many others. Now, we are working in blood, vitamin D, HBA1C, lipid profile, PSA for prostate cancer, HIV and in saliva as well. Essentially, we have built a tech platform wherein we can very easily add new and new tests. After building the test, the first thing we have to do is get a medical license and validation. So, we have done clinical validation study, we have a specificity of 99% and sensitivity of 96%. Today, we are mostly working in the B2B sectors. We are working with many pharma companies like AstraZeneca, CIPLA, Bayer. Via them, we are able to sell to doctors. We are live with more than 4,000 doctor clinics across India, rest of Asia and Africa. We are working with government and public health organizations. We also partner with other healthcare companies. We integrate our solution into their software and wherein the customers can do the test using their app and they can create more engagement and use case. Lastly, we are also selling direct to consumer. In India, we are available on online marketplaces like Amazon. We have two different apps, one for each use case. So, one is meant for a customer. If you're lucky enough to get a sample today, you can take it home, do a test using the consumer app that you see on the left. And on the right is the healthcare provider app, which is meant for doctors, paramedics and staff. Wherein they can do the test on your behalf on their phone in the clinic and share the report with you. We have won multiple awards, but really one thing that has been really nice is getting so much customer love. We have got more than 4.7 rating on Amazon in India. We have helped treat a lot of women for UTI. We have helped diagnose a lot of people for chronic kidney disease. If we hadn't identified or diagnosed them, generally kidney diseases are diagnosed much later in life. It might have been too late wherein they would be requiring dialysis or kidney failure. By identifying this early, we help them get on treatment early and probably even prevent dialysis for the rest of their life. We've been lucky to be backed by some amazing investors, one of them being Y Combinator. Thank you. We are at the AstraZeneca booth right behind the stage. In case you want to discuss more with us, we are right here.